[Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)]
- PMID: 123842
[Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)]
Similar articles
-
[The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].Clin Ter. 1978 Mar 15;84(5):509-21. Clin Ter. 1978. PMID: 648104 Italian. No abstract available.
-
[Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].Minerva Med. 1974 Nov 21;65(83):4315-29. Minerva Med. 1974. PMID: 4279362 Italian. No abstract available.
-
[Antithrombogenic action of a new extract: 3GS].Minerva Cardioangiol. 1975 Sep;23(9):565-70. Minerva Cardioangiol. 1975. PMID: 125860 Italian. No abstract available.
-
Treatment of coronary atherosclerosis.Mod Treat. 1966 May;3(3):565-78. Mod Treat. 1966. PMID: 5326566 Review. No abstract available.
-
[Effect of Atromid on blood lipids in patients with hyperlipemia].Ter Arkh. 1968 Mar;40(3):15-20. Ter Arkh. 1968. PMID: 4875984 Review. Russian. No abstract available.